A Curated Platform of Equity & Options Market Intelligence
Select Page

ABUS

Search by
TICKER SYMBOL

Arbutus Biopharma Corp

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

2.6

0.11

(4.418%)

Volume:

0

52 week range:

1.69 - 3.12

Market Cap:

466.68M

Company Description:

arbutus biopharma corporation (nasdaq:abus) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis b infection, a disease of the liver caused by hepatitis b virus (hbv). we are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the hbv treatment landscape and cure hepatitis b virus disease. in addition to our hbv assets, we are developing a pipeline of programs that leverage our expertise in rna interference (rnai) therapeutics and our lipid nanoparticle (lnp) technology.